On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...

A coroner overseeing the inquest of a woman who died following a Covid vaccine has stood down amid claims of bias and ...

COVID Vaccines Linked to Autoimmune Disease** In a groundbreaking development, recent research has unveiled that COVID-19 vaccines may act as a trigger for ...

Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

AIM ImmunoTech (AIM) announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company’s ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

AstraZeneca ‘very disappointed’ after ditching £450m Liverpool vaccine site - Pascal Soriot, chief executive of AstraZeneca, ...

AstraZeneca has halted plans to build a £450 million vaccine plant in the UK due to decreased government support, prompting ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...